Interferon alfa (Swedish Orphan Biovitrim)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa (Swedish Orphan Biovitrim)
Drug Alias Name干扰素Interferon alpha (Swedish Orphan Biovitrim)MultiferonLeu-IFNHuIFN-alpha-Le
ClassificationBiologics > Protein drugs > Non-recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple SclerosisMelanomaLeukemia, Myelogenous, Chronic +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesViragen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Copenhagen
Active IndicationsMelanomaLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[5] 
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeL03AB01
Related LinksWikipediaDrugBankKEGG